Altimmune, Inc. (ALT)
2.85
-0.04
(-1.38%)
USD |
NASDAQ |
Apr 24, 16:00
2.88
+0.03
(+1.05%)
After-Hours: 20:00
Altimmune Market Cap : 370.80M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 789.69B |
| Amgen, Inc. | 185.74B |
| Madrigal Pharmaceuticals, Inc. | 11.75B |
| CorMedix, Inc. | 586.55M |
| Viking Therapeutics, Inc. | 3.784B |
Market Cap Related Metrics
| PS Ratio | 6031.17 |
| Price to Book Value | 1.649 |
| Price | 2.85 |
| Earnings Yield | -35.63% |